Over one billion people worldwide are predicted to harbor Toxoplasma infection frequently with unknown lifelong health consequences. Toxoplasmosis is an important cause of foodborne, inflammatory illnesses, as well as congenital abnormalities. Ubiquitous Toxoplasma has a unique tropism for central nervous system with a mind-bugging effect and is transmitted sexually through semen. Currently available therapies are ineffective for persistent chronic disease and congenital toxoplasmosis or have severe side effects which may result in life-threatening complications. There is an urgent need for safe and effective therapies to eliminate or treat this cosmopolitan infectious and inflammatory disease. This investigation discusses pathogenesis of maternal and congenital toxoplasmosis, the currently available therapies in practice, and the experimental therapeutic modalities for promising future trials.
Digital Object Identifier (DOI)
This work was supported in part by a grant from National Institutes of Health NIH-DE019177 (Helieh S. Oz).
Oz, Helieh S., "Maternal and Congenital Toxoplasmosis, Currently Available and Novel Therapies in Horizon" (2014). Internal Medicine Faculty Publications. 74.